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Abstract: 
A significant (>70%) number of drugs entering the market present low solubility in water1. To minimize 
this problem, which impacts on dissolution, absorption, and therapeutic efficacy of drugs in dosage forms, 
several techniques have been employed, namely micronization or selection of a defined polymorph2. The 
production of amorphous solid dispersions of drugs is regarded as one of the most powerful approaches 
for solubility enhancement. However, since amorphous substances are thermodynamically unstable, they 
tend to convert back into a stable crystalline lattice. This conversion can be delayed by combination of 
substances producing co-amorphous mixtures2,3, due to bond formation between individual molecules, 
thus preventing crystal formation2. The aim of this study was to assess the potential of several excipients 
for the production of stable co-amorphous entities containing olanzapine, a poorly water soluble 
antipsychotic drug.  
Mixtures of olanzapine with amino acids, carboxylic acids and saccharin were produced in a 1:1 molar 
ratio by quench cooling. The mixtures were characterized by NIR to detect interactions between the 
molecules of each compound and the combination of DSC with XRPD to assess the formation of different 
polymorphic forms of olanzapine. Solubility studies were performed to evaluate the increase in water 
solubility of the drug. 
Thermal analysis and XRPD revealed that mixtures of olanzapine and L-proline, citric acid, tartaric acid and 
saccharin were the most promising for the production of co-amorphous mixtures. NIR spectra of these 
mixtures show an increase in the intensity of absorbance in OH regions and the appearance of a band 
related to NH-OH interaction, likely due to bond formation. The thermograms derived from calorimetric 
studies did not show any endotherms related to melting of materials. Furthermore, the systems resulted 
in increased drug solubility, ranging between 28 for L-proline and 57 times when saccharin was used. 
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